Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

y be necessary due to hepatotoxicity, other nonhematologic adverse events, or hematologic adverse events. Therapy with Gleevec was discontinued for adverse events in 5% of patients at both dose levels studied

Patients with severe hepatic impairment should be treated at a starting dose of 300 mg/day and should be closely monitored

Gleevec is metabolized by the CYP3A4 isoenzyme and is an inhibitor of CYP3A4, CYP2D6, and CYP2C9. Dosage of Gleevec should increase by at least 50%, and clinical response should be carefully monitored, in patients receiving Gleevec with a potent CYP3A4 inducer such as rifampin or phenytoin. Examples of commonly used drugs that may significantly interact with Gleevec include acetaminophen, warfarin, erythromycin, and phenytoin. (Please see full Prescribing Information for other potential drug interactions)

For daily dosing of 800 mg and above, dosing should be accomplished using the 400 mg tablet to reduce exposure to iron

Use of Gleevec tablets is contraindicated in patients with hypersensitivity to imatinib or to any other component of Gleevec tablets

Women of childbearing potential should be advised to avoid becoming pregnant while taking Gleevec tablets and should be advised to avoid breast- feeding while taking Gleevec tablets because of the potential for serious adverse reactions in nursing infants

Common Side Effects of Gleevec Tablets

The majority of patients who received Gleevec in the GIST study experienced adverse events at some time. Most adverse events were mild to moderate in severity. The most frequently reported adverse events (400 mg/day; 600 mg/day) (all Grades) were superficial edema (81%; 77%), nausea (63%; 74%), muscle cramps (47%; 58%), diarrhea (59%; 70%), fatigue (48%; 53%), abdominal pain (40%; 37%), rash and related terms (38%; 53%), vomiting (38%; 35%) musculoskeletal pain (37%; 30%), and hemorrhage (26%; 34%)**

Supportive care may help management of some mild
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:9/2/2015)... 2015 About Duchenne muscular dystrophy ... generally affects the male population. It is characterized ... is caused due to mutations in the dystrophin ... of dystrophin (a protein essential for maintaining healthy ... weakens muscle function, causes loss of ambulation, harms ...
(Date:9/2/2015)... , Sept. 2, 2015 About Chronic Lymphocytic ... malignant condition characterized by increased production of lymphocytes. It ... and then it can spread to other parts of ... stages because of the slow buildup of the cancerous ... spreads to the spleen, liver, and lymph nodes. The ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... , ... (OTC Bulletin Board: HFGB), a leading developer and producer,of plant ... food production in Xi,an, China, today reported that in its,third ... Revenues for the quarter ended Sept. ...
... , NORTH HOLLYWOOD, Calif., Nov. ... a leading national hospitalist physician group practice company, announced today that ... ACP Hospitalist as one of the 2009 Top Ten Hospitalists ... of the magazine. , Dr. Vaidyan has been a practicing physician ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, ... of Atlanta to help support childhood cancer research. On June 17, 2014, ... Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... interim clinical staffing companies, has completed a recapitalization with new investment partners ... BPOC and Heritage Group each offer extensive expertise and connections within the ...
(Date:9/2/2015)... ... ... Every year at this time, students prepare to go back to school. Some ... academic workload confronting them. They just don’t have the skills needed to do their ... how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job of a ...
(Date:9/2/2015)... ... , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) sheds light ... on consumers. It was reported that 33% are paying an average of $39 more ... extra $100 compared to last year. Among the drugs that saw the highest increases ...
(Date:9/2/2015)... ... September 02, 2015 , ... World Patent Marketing, a vertically ... safety invention that protects people from crime and other hostile situations. , "The ... CEO and Creative Director of World Patent Marketing. "The industry is growing at ...
Breaking Medicine News(10 mins):Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... , TUESDAY, Dec. 6 (HealthDay News) -- Different molecular mechanisms ... aging of the reproductive system, new research with worms suggests. ... begins to decline after age 35 but other cells in ... later, study author Coleen Murphy of Princeton University said in ...
... (HealthDay News) -- Low levels of vitamin D are much ... obese and are associated with insulin resistance, a risk factor ... included 411 obese children and 87 children who weren,t overweight. ... serum insulin, body mass index and blood pressure. The ...
... rise and 48 percent of all breast cancers occur in ... to have breast reconstruction. A new study from Wake ... after mastectomy is safe for older women. The answer is ... the psychological, social and sexual well-being of the patient, establishing ...
... center and Universit Laval have discovered the likely cause ... more than 10 million North Americans. The team,s promising ... scientific journal Brain . Frequently confused with ... disorder. An estimated 4% of the population over 40 ...
... first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, ... Center New Orleans, reports that a significant number of ... and what factors contribute. The research is published online ... 5, 2011 Early Release section. The research team, which ...
... ( Marmota marmota ) live in extended family groups ... of a dominant territorial pair and a number of ... Over a 14-year period, Klaus Hacklnder of the Institute ... Resources and Life Sciences, Vienna and Walter Arnold of ...
Cached Medicine News:Health News:Research With Worms May Shed Light on Women's Fertility 2Health News:Vitamin D Levels Tied to Diabetes Risk in Obese Kids 2Health News:Advanced age should not deter women from breast reconstruction after cancer 2Health News:LSUHSC research finds many women not receiving recommended breast cancer adjuvant treatment 2Health News:LSUHSC research finds many women not receiving recommended breast cancer adjuvant treatment 3Health News:Hanging with the boys - female Alpine marmots benefit from a bit of pre-natal testosterone 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: